Sitagliptin Versus Placebo to Reduce the Incidence and Severity of Posttransplant Diabetes Mellitus After Kidney Transplantation—A Single-center, Randomized, Double-blind Controlled Trial

Postkidney transplant diabetes mellitus (PTDM) affects cardiovascular, allograft, and recipient health. We tested whether early intervention with sitagliptin for hyperglycemia (blood glucose >200 mg/dL) within the first week of transplant and discontinued at 3 mo could prevent development of PTDM...

Descripción completa

Detalles Bibliográficos
Autores principales: Delos Santos, Rowena B., Hagopian, Jennifer C., Chen, Ling, Ramakrishnan, Madhuri, Wijeweera, Helen, Klein, Christina L., Brennan, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Clinical Science—General
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125117/
https://www.ncbi.nlm.nih.gov/pubmed/36279020
http://dx.doi.org/10.1097/TP.0000000000004373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125117/
https://www.ncbi.nlm.nih.gov/pubmed/36279020
http://dx.doi.org/10.1097/TP.0000000000004373

Ejemplares similares